The FDA has accepted for Priority Review the sNDA for finerenone for heart failure with mildly reduced or preserved ejection fraction.

The FDA has removed the risk evaluation and mitigation strategies (REMS) program requirement for Tryvio (aprocitentan).

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

A study has found that, in the United States, hypertension control rates vary by race, ethnicity, and geography among veterans.

Weekend work and long work hours were associated with insomnia symptoms, difficulty falling asleep, and poor sleep quality.

Doctors at Duke Health have successfully performed the world’s first living mitral valve replacement, saving three lives in North Carolina.

In patients with type 2 diabetes, cardiovascular autonomic neuropathy is associated with increased risk of mortality in women.

A combination of low blood pressure and high intraocular pressure can predict RNFL thinning in moderate-to-severe glaucoma.

An updated guideline has been published by the AHA, ACC, and other organizations regarding the management of acute coronary syndrome.

In patients with CKD, hyperkalemia significantly increases risk for major adverse cardiovascular events and arrhythmia.

Boston Scientific has issued a recall of Accolade pacemaker devices due to an increased risk for permanently entering Safety Mode.

Skeletal Muscle Index decreased as Metabolic Score for Visceral Fat increased, which was most significant among those with diabetes and obesity.